Elsevier Launches New Open Access Journal in Biomedicine: Journal of Clinical and Translational Endocrinology

Elsevier Launches New Open Access Journal in Biomedicine: Journal of Clinical
                       and Translational Endocrinology

  PR Newswire

  NEW YORK, September 12, 2013

NEW YORK, September 12, 2013 /PRNewswire/ --

Elsevier , a world-leading provider of scientific, technical and medical
information products and services, is pleased to announce the launch of a new
open access research publication - Journal of Clinical and Translational
Endocrinology (JCTE).

The scope of this new journal is patient-oriented research in a variety of
disciplines in endocrinology, including diabetes, metabolic bone disease and
osteoporosis, thyroid disease, pituitary and lipid disorders. Areas of high
priority include novel pilot/proof-of-concept clinical trials in humans and
basic science research involving human specimens.

Dr. Vin Tangpricha from Emory University, Atlanta, Editor-in-Chief of the
journal, said, " Journal of Clinical and Translational Endocrinology will
provide authors a unique home for manuscripts focused on patient-oriented
endocrinology research that translates basic science research to clinical
applications for patients with endocrine diseases. As a practicing clinician
and a researcher in endocrinology, I understand the importance of
strengthening the relationship between the clinical and basic sciences.We
look forward to providing the scientific community with high-yield content
that addresses the needs of readers and investigators interested in
translational research of endocrine diseases."

Andrew Miller, Executive Publisher at Elsevier, added, " Journal of Clinical
and Translational Endocrinology will offer the research community a unique and
dynamic blend of tradition and innovation: editorial review from an expert
team of researchers together with our publishing and dissemination systems,
involving innovative, digital approaches. Elsevier is very pleased to launch
JCTE and work with Dr. Tangpricha and the journal editors to serve the needs
of endocrinologists internationally."

For more information or to submit an article, go to: www.JCTEjournal.com . The
journal is ready to accept submissions.

About the Edi to r-in-Chief: Dr. Vin Tangpricha, MD, PhD

Dr. Vin Tangpricha is an Associate Professor of Medicine at Emory University
School of Medicine in the Division of Endocrinology, Metabolism and Lipids. He
received his M.D. at Tufts University and completed his internal medicine
residency and endocrinology fellowship at Boston University Medical Center. He
completed a PhD in Molecular Medicine on the topic of colon cancer and vitamin
D. Dr. Tangpricha has published a number of manuscripts investigating the role
of vitamin D in patients with chronic kidney disease, cystic fibrosis, and
infections including HIV and TB. He is currently conducting a number of
clinical trials to translate findings from the bench that suggest that vitamin
D may play an important role in improving outcomes in patients with
infections.

About Open Access Publishing at Elsevier

Elsevier has been providing open access publishing options since 2005. Today,
researchers can choose to publish open access in over 1,600 established
peer-reviewed journals as well as 52 full open access journals and these
numbers will continue to grow rapidly. All of Elsevier's open access
publications have been peer reviewed, ensuring that the broader community not
only reads the latest research but that it is factual, original and of the
highest quality and ethical standards. For more information about Elsevier's
open access program, visit www.elsevier.com/openaccess

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , SciVal , Reaxys , ClinicalKey and Mosby's
Suite , which enhance the productivity of science and health professionals,
helping research and health care institutions deliver better outcomes more
cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group plc , a world leading
provider of professional information solutions. The group employs more than
30,000 people, including more than 15,000 in North America. Reed Elsevier
Group plc is owned equally by two parent companies, Reed Elsevier PLC and Reed
Elsevier NV.

Their shares are traded on the London, Amsterdam and New York Stock Exchanges
using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK
and ENL.

Media contact Brant Emery Elsevier +31(0)20-485-3310 b.emery@elsevier.com